Identifying The Human Calcineurin Signaling Network

识别人类钙调神经磷酸酶信号网络

基本信息

  • 批准号:
    9276716
  • 负责人:
  • 金额:
    $ 48.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-01 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The absence of experimental and computational tools for global identification of phosphatase substrates leaves a major gap in our understanding of cellular regulatory networks and prevents systems-level analyses of phosphatase signaling. The proposal addresses this knowledge gap by systematically identifying targets of calcineurin (CN), the ubiquitous Ca2+/calmodulin-dependent protein phosphatase and target of immunosuppressants, FK506 and cyclosporin A. Only 25 substrates are currently attributed to CN in mammals--the same as in yeast, whose proteome is ~tenfold smaller, and chronic inhibition of CN in patient's cause's side-effects by disrupting unidentified regulatory events. This suggests that in humans, the majority of CN substrates, and thus its regulatory functions, remain to be identified. Recent insights into CN substrate recognition drive our approach: CN binds to short linear motifs (SLiMs), termed PxIxIT and LxVP, which can occur hundreds of residues away substrate dephosphorylation sites. Mutating these motifs or preventing their binding to conserved surfaces on CN, i.e. with FK506, CysA, or viral inhibitor A238L, blocks dephosphorylation. Building upon our previous success establishing the CN signaling network in yeast, we are determining human CN substrates by systematically identifying CN- binding peptides in the proteome, which is challenging due to their low affinities and degenerate sequences. This work aims to 1) systematically discover human PxIxIT and LxVP-type sequences by synergizing experimental and computational methods. CN-binding sequences are directly selected from phage display libraries that contain all disordered regions of the human proteome, where SLiMs reside. PxIxITs are also identified in silico by leveraging their characteristic structural features and using a novel method to predict binding to the conserved PxIxIT-docking surface on CN. Candidate sequences are validated for CN-binding in vitro, and in Aim 2 their parent proteins are tested for interaction with and/or dephosphorylation by CN in cultured animal cells. In Aim 3 we characterize the functions and binding mode of a newly discovered CN-binding motif, YLxxLF, which may identify a distinct class of CN- interacting proteins and provide avenues for selective disruption of CN signaling events. This systems- level analysis of CN signaling in humans will ultimately identify intersections with other regulatory networks that can be exploited therapeutically, such as providing strategies to ameliorate immunosuppressant side effects. Furthermore, this work will provide fundamental insights into how phosphatases achieve specificity and will create a critical new resource for researchers studying Ca2+ or phosphorylation-dependent regulation of protein function.
 描述(通过应用程序提供):缺少用于磷酸酶底物的全球鉴定的实验和计算工具在我们对细胞调节网络的理解中留下了一个重大差距,并阻止了磷酸酶信号传导的系统级分析。该提议通过系统地识别钙调神经酶(CN)的靶标,无处不在的Ca2+/钙调蛋白依赖性蛋白质磷酸酶以及免疫抑制剂,FK506和环孢菌素A的靶标解决了这一知识差距。目前,只有25个底物归因于Cn的较小的蛋白质,其在YEAST中是较小的,其蛋白质是在YEAST中属于CN的25个。患者的副作用通过破坏身份不明的监管事件来产生。这表明,在人类中,大多数CN底物及其调节功能仍有待鉴定。对CN底物识别的最新见解可以推动我们的方法:CN与短线性基序(Slim)结合,称为PXIXIT和LXVP,这可能会出现数百个残留物,从而将底物去磷酸化位点远离。突变这些基序或防止其与CN上配置的表面的结合,即用FK506,CYSA或病毒抑制剂A238L阻止去磷酸化。在我们以前的成功建立CN信号网络中的基础上,我们通过系统地识别蛋白质组中的CN结合肽来确定人类CN底物,这是由于其低亲和序列而受到挑战。这项工作的目的是1)通过协同实验和计算方法来系统地发现人类pxixit和LXVP型序列。 CN结合序列是直接从包含Slims居住的人类蛋白质组的所有无序区域的噬菌体显示库中选择的。在计算机中还可以通过利用其特征性结构特征并使用新颖的方法来预测CN上配置的PXIXIT-docking表面的结合来确定PXIXIT。候选序列在体外进行了CN结合验证,在AIM 2中,他们的母蛋白与CN在培养的动物细胞中的相互作用和/或去磷酸化进行了测试。在AIM 3中,我们表征了新发现的CN结合基序YLXXLF的功能和结合模式,该图案可以识别一类不同的CN-相互作用蛋白,并为选择性破坏CN信号事件提供途径。该系统级别对人类中CN信号的分析将最终确定可以热探索的其他调节网络的交叉点,例如提供减轻免疫抑制副作用的策略。此外,这项工作将提供有关磷酸酶如何达到特异性的基本见解,并为研究CA2+或磷酸化依赖性蛋白质功能调节的研究人员创造关键的新资源。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Martha S. Cyert的其他基金

Systematic elucidation of calcineurin phosphatase signaling in humans
系统阐明人类钙调神经磷酸酶信号传导
  • 批准号:
    10596473
    10596473
  • 财政年份:
    2020
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
Systematic elucidation of calcineurin phosphatase signaling in humans
系统阐明人类钙调神经磷酸酶信号传导
  • 批准号:
    10371219
    10371219
  • 财政年份:
    2020
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
Systematic elucidation of calcineurin phosphatase signaling in humans
系统阐明人类钙调神经磷酸酶信号传导
  • 批准号:
    10818737
    10818737
  • 财政年份:
    2020
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
Discovering the mechanisms and functions of signaling by the calcineurin beta1 isoform
发现钙调神经磷酸酶 beta1 亚型的信号传导机制和功能
  • 批准号:
    9921418
    9921418
  • 财政年份:
    2019
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
HPH1 AND HPH2 ARE NOVEL COMPONENTS OF THE SEC63/SEC62 COMPLEX
HPH1 和 HPH2 是 SEC63/SEC62 复合体的新颖成分
  • 批准号:
    8365855
    8365855
  • 财政年份:
    2011
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
Role of Ca2+/Calcineurin Signaling in S.Cerevisiae
Ca2/钙调磷酸酶信号在酿酒酵母中的作用
  • 批准号:
    7930987
    7930987
  • 财政年份:
    2009
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
DEPHOSPHORYLATION OF CRZ1 BY CALCINEURIN
钙调磷酸酶对 CRZ1 的去磷酸化
  • 批准号:
    6979543
    6979543
  • 财政年份:
    2004
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
ROLE OF PKC1
PKC1 的作用
  • 批准号:
    6979547
    6979547
  • 财政年份:
    2004
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
PROTEIN COMPLEXES CONTAINING CALCINEURIN AND CRZ1P
含有钙调磷酸酶和 CRZ1P 的蛋白质复合物
  • 批准号:
    6979690
    6979690
  • 财政年份:
    2004
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
CA2+ AND CALICNEURIN DEPENDENT TWO-HYBRID INTERACTIONS
CA2 和钙调磷酸酶依赖性双杂交相互作用
  • 批准号:
    6979679
    6979679
  • 财政年份:
    2004
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:

相似国自然基金

基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
  • 批准号:
    51009131
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
  • 批准号:
    50178004
  • 批准年份:
    2001
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

Supplement for Role of Environmental Weathering and Gastrointestinal Digestion on the Bioavailability and Toxicity of Microplastic and Cadmium Mixtures
补充环境风化和胃肠消化对微塑料和镉混合物的生物利用度和毒性的作用
  • 批准号:
    10854398
    10854398
  • 财政年份:
    2023
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
  • 批准号:
    10726508
    10726508
  • 财政年份:
    2023
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
Multidomain Peptide Hydrogels as a Therapeutic Delivery Platform for Cancer Treatment
多域肽水凝胶作为癌症治疗的治疗传递平台
  • 批准号:
    10743144
    10743144
  • 财政年份:
    2023
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease
CD98hc 脑穿梭机为阿尔茨海默病提供现成的神经保护抗体
  • 批准号:
    10566062
    10566062
  • 财政年份:
    2023
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别:
PAIRS: Validating telomerase reverse transcriptase (TERT) as an intrinsic vulnerability toward sensitizing cancer to radiation
配对:验证端粒酶逆转录酶 (TERT) 作为癌症对辐射敏感的内在脆弱性
  • 批准号:
    10718390
    10718390
  • 财政年份:
    2023
  • 资助金额:
    $ 48.31万
    $ 48.31万
  • 项目类别: